EuroSIDA Publications 2026

1. Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. Kraef C, Ryom L, Kirk O; writing group and the RESPOND study group.
   Eur Respir J. 2026;67(3):2502523.  Abstract

2. Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations.  Han WM, Neesgaard B, Knappik M, Cavassini M, Abela IA, Timiryasova A, Greenberg L, Martin C, Mussini C, Wit F, Sabin C, Castagna A, Abutidze A, El-Sadr W, Bonnet F, Sarcletti M, Carlander C, Hachfeld A, Weis N, Vannappagari V, Rogatto FP, Young LA, Hosein SR, Ryom L, Petoumenos K; D:A:D; RESPOND collaborations.
   EClinicalMedicine. 2026;91:103739.  Abstract